Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Termination of pregnancies of < 6 weeks gestation with a single dose of 800 mu g of vaginal misoprostol
Author: Bugalho, A
Mocumbi, S
Faundes, A
David, E
Abstract: This study evaluated the effectiveness of a single dose of the abortifacient effect of vaginal misoprostol followed by prolonged observation. Women with less than or equal to 42 days of amenorrhea, pregnancy confirmed by ultrasound and approved request for termination received 800 mu g of vaginal misoprostol once and were observed for 1 week. The gestational sac was measured before misoprostol administration, and 24 h and 7 days afterward. Women reported bleeding, expulsion of sac, and other complaints. After 1 week, those who had not aborted received a second dose of 800 mu g. Those who had not aborted by 24 h later were treated by Vacuum aspiration of the endometrial cavity. Twenty-four hours after treatment, 71.8% had aborted, and 87.1% aborted 3 days after treatment. After the second dose, 7 days later, the cumulative abortion rate leached 92.1%. None of the subjects who aborted required curettage or vacuum aspiration. The main complaints were pain (84.5%), nausea (21.4%), and headache (17.5%). No clinical differences between responders and nonresponders was found. Vaginal misoprostol, 800 mu g, is effective in inducing early termination of pregnancy and there is no need for an additional dose within 72 h after the first administration of misoprostol. CONTRACEPTION 2000;61:47-50 (C) 2000 Elsevier Science Inc. All rights reserved.
Subject: misoprostol
early abortion
Country: EUA
Editor: Elsevier Science Inc
Citation: Contraception. Elsevier Science Inc, v. 61, n. 1, n. 47, n. 50, 2000.
Rights: fechado
Identifier DOI: 10.1016/S0010-7824(99)00116-X
Date Issue: 2000
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
WOS000086370900007.pdf92.51 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.